Navigation Links
China reveals new outbreak of foot-and-mouth disease

Even as China is trying to contain Bird flu, an outbreak of foot-and-mouth disease forced the killing of 91 cattle in the northeastern part of the country this week // .

The official Xinhua News Agency reported that Cattle on a farm in Shandong province developed symptoms this month.

The culling commenced on December 29 after cattle were found to have contracted the disease.

Xinhua said the provincial government has since quarantined the farm where the outbreak occurred, and ordered inoculations for animals in the area.

Foot-and-mouth disease causes severe weight loss in cattle. It does not affect human beings and outbreaks are relatively easy to control; but the disease can have a serious economic impact on the livestock industry.

Beijing has kept outbreaks of the disease hidden in the past.

This year alone, China has killed and incinerated thousands of head of cattle to control the outbreak of the Asia type 1 foot-and-mouth disease, officials say.

Outbreaks have been reported on the outskirts of Beijing, neighbouring Hebei province, eastern Jiangsu province, the western region of Xinjiang, and in Shandong. However, officials in the animal feed industry say Beijing has failed to report the full extent of the disease's spread.
'"/>




Page: 1

Related medicine news :

1. China tells officials not to hide SARS damage
2. China reports declining number of SARS Cases
3. China says patient may have SARS
4. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
5. Adverse Effects Associated with Unauthorised Hepatitis A Vaccine in China
6. Pig Bacterium (Streptococcus suis) Kills 24 In China
7. Watch Out! Pollution hazard from E-waste recycling in India & China
8. French Fries In Cancer Controversy In China
9. China To Distribute Free Condoms To Combat AIDS/HIV
10. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
11. India And China Discuss Import Of Encephalitis Vaccine
Post Your Comments:
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
(Date:12/5/2009)... Solutions, an innovative new international private medical insurance plan which follows ... offering customers the flexibility to add or remove a wide range ... customers to tailor their benefits to complement those already offered in ... ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ) ("Care" ... declared a dividend of $0.17 per share of common stock. ... of record on December 14, 2009. ,, ... a real estate investment and finance company investing in healthcare-related real ...
(Date:12/4/2009)... and Services for the Aging (AAHSA) applauds the Senate for ... provisions remain in the final health reform legislation . The ... with disabilities and their caregivers. ,, We urge the ... make it affordable to care for families and caregivers. , ...
(Date:12/4/2009)... 4 Pamela Bowen, Chief Information Officer at Crescent ... Innovation Officer" Appy Award for transforming Crescent,s business with ... nominated based on their innovative usage of Salesforce CRM ... customer success to their sales, marketing, partner, service, support ...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... PHILADELPHIA, Oct. 1 The national law ... announced that it is forming a,Professional Liability practice ... Hoffman including name partner Peter Hoffman. The group ... Eckert Seamans, Philadelphia,and Harrisburg offices and create a ...
... 1 AnnTaylor Stores Corporation,(NYSE: ANN ), a ... be,stepping up its support of women around the world ... sale of its ANN Cares,Card in- store and on-line. ... 30, 2007 through,October 31, 2007 and will entitle cardholders ...
... IN COMMUNICATIONS, COORDINATION, ... DEATHS, LOSSES, RICHMOND, Va., Oct. 1 In the ... the U.S., a,repeat of 2005,s medical catastrophes and loss of ... Global Secure, a leading provider,of emergency preparedness and response systems ...
... BOSTON, Oct. 1 The Regulatory Affairs,Professionals ... the,global healthcare products regulatory profession, announced at ... of "Regulatory Affairs Professional,Development Framework: An Overview," ... and abilities of regulatory professionals. The ...
... Architect to Build on Foundation,s Momentum In Pursuing ... ... The Michael J. Fox,Foundation for Parkinson,s Research (MJFF) today announced ... been,appointed Interim Chief Executive Officer. Ms. Hood, who joined the,Foundation in ...
... Educational ... Resource at IDSA Annual Meeting, HADDON HEIGHTS, N.J., Oct. ... continuing education,resource as part of their exhibit booth at the ... October 4-7, in San Diego,California. Project CDAD: Outbreak Prevention and ...
Other Medicine News:Health News:Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg 2Health News:Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg 3Health News:Ann Taylor Launches ANN Cares Card to Support Fight Against Breast Cancer 2Health News:Natural Disaster Rescue Teams at Public Health Facilities Across the Country Learn from Katrina Failures 2Health News:Natural Disaster Rescue Teams at Public Health Facilities Across the Country Learn from Katrina Failures 3Health News:New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals 2Health News:New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals 3Health News:Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation 2Health News:National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks 2
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawford presented ... analysis of secondary end points of biochemical recurrence rate ... degarelix for injection) or monthly leuprolide in prostate cancer ... cancer patients who received FIRMAGON 240/80 mg/month had a ...
(Date:12/4/2009)... Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity ... among the comorbidities reported to occur more often ... with epilepsy versus those without an epilepsy diagnosis, ... across the U.S. ,, Findings from " CNS-Related ...
(Date:12/3/2009)... and STATE COLLEGE, Pa., Dec. 3 Ambry ... an agreement to provide extended bioinformatics genomics services ... performed at Ambry. ,, (Logo: ... CSO said, "Our team at Ambry has been ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3New DNA and RNA aptamers offer unique therapeutic advantages 9488 1New DNA and RNA aptamers offer unique therapeutic advantages 9488 21957 58 Flu Pandemic Can Provide Clues to Planning for h1n1 53765 11957 58 Flu Pandemic Can Provide Clues to Planning for h1n1 53765 2Recondo Technology Introduces New Software Service for Hospitals 53761 1Recondo Technology Introduces New Software Service for Hospitals 53761 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: